BioSpace News Archive

With cases of coronavirus COVID-19 disease rising at an unprecedented rate, CTK has taken their proven strength in developing infectious disease diagnostics and in collaboration with its partners in China , has proudly launched two diagnostic tests for this virus, both a real time PCR based nucleic acid detection kit and a serologic

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts via a new Coronavirus Toolkit featuring relevant models and services. Mouse models have been extensively used for research on the SARS-CoV virus, closely related to the new SARS-CoV-2 virus that causes COVID-19. Taconic offers many animal models and services to support COVID-19 research and em

New services will reduce burden on hospitals by enabling home health care agencies to serve 14,500 patients dail

PALO ALTO, Calif. , March 20, 2020 /PRNewswire/ -- The COVID Q&A bot answers questions on the coronavirus symptoms, prevention, and treatment, among other things. It helps people concerned about the coronavirus outbreak to quickly get answers to their burning questions. The bot relies on the information from the Centers for Disease Control and Prevention (CDC) and the Worl

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that ImStem Biotechnology, Inc. (Farmington, CT), a biopharmaceutical company pioneering the development of mesenchymal stem cells (hES-MSC) derived from human embryonic stem cells has received notification from the U.S. Food and Drug Administration (FDA) th

Molecular diagnostics company Lucence announced today the development of the SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) kit, a sample collection medical device to facilitate more accessible testing of viral infections such as COVID-19. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200320005151/en/ Genomics Company Luce

Simultaneous approval of VOCABRIA (cabotegravir oral tablets), for short-term treatment in conjunction with CABENUVA (cabotegravir and rilpivirine extended-release injectable suspensions), also granted by Health Canada CABENUVA reduces treatment dosing days from 365 to 12 per year

In Partnership with Alto Pharmacy, Kits Will Provide Guidance to More Patients and Lessen Strain on Overburdened Clinics

Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.18 per issued and outstanding share. The cash dividend will be payable on April 17, 2020, to shareholders of record as of the close of business on April 3, 2020. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to approval by its Bo

German companies CureVac and BioNTech were both in the headlines this week as companies working overtime to develop a vaccine to prevent the spread of coronavirus.